Evidence map›Paper›PMID 24478405›Full record

ArticleJournal of clinical microbiology2014

Potential impact of a microarray-based nucleic acid assay for rapid detection of Gram-negative bacteria and resistance markers in positive blood cultures.

Nicasio Mancini, Laura Infurnari, Nadia Ghidoli, Grazia Valzano, Nicola Clementi, Roberto Burioni, Massimo Clementi

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Rapid commercial CTX-M diagnostics: Performance, limitations and clinical impact.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. [Multiple PCRRevista espanola de salud publica · 2023
    Observational
  6. Observational
  7. Observational
  8. Review
  9. Article
  10. Review
  11. Rapid Detection ofFrontiers in cellular and infection microbiology · 2021
    Article
  12. Rapid Detection of Methicillin-ResistantDiagnostics (Basel, Switzerland) · 2020
    Review
  13. Article
  14. Evaluation of two rapid molecular test systems to establish an algorithm for fast identification of bacterial pathogens from positive blood cultures.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  15. Article
  16. Article
  17. Gut Colonization Preceding Mucosal Barrier Injury Bloodstream Infection in Pediatric Hematopoietic Stem Cell Transplantation Recipients.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2019
    Article
  18. Nanosphere's VerigeneClinical hematology international · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicasio ManciniLaboratorio di Microbiologia e Virologia, Università Vita-Salute San Raffaele, Milan, Italy.
Laura Infurnari
Nadia Ghidoli
Grazia Valzano
Nicola Clementi
Roberto Burioni
Massimo Clementi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the Verigene Gram-negative blood culture (BC-GN) test, a microarray that detects Gram-negative bacteria and several resistance genes. A total of 102 positive blood cultures were tested, and the BC-GN test correctly identified 97.9% of the isolates within its panel. Resistance genes (CTX-M, KPC, VIM, and OXA genes) were detected in 29.8% of the isolates, with positive predictive values of 95.8% (95% confidence interval [CI], 87.7% to 98.9%) in Enterobacteriaceae and 100% (95% CI, 75.9% to 100%) in Pseudomonas aeruginosa and negative predictive values of 100% (95% CI, 93.9% to 100%) and 78.6% (95% CI, 51.0% to 93.6%), respectively.

Indexed as

Drug Resistance, BacterialBacteremiaGram-Negative BacteriaGram-Negative Bacterial InfectionsHumansMicroarray AnalysisMolecular Diagnostic TechniquesPilot ProjectsPredictive Value of TestsSensitivity and Specificity

Identifiers

PMID24478405
PMCPMC3993469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.